Skip to content

Efficacy of Aswagandha and Mandookaparni in Manodwega (GAD) patients

Clinical evaluation of A comprehensive Ayurvedic intervention in Manodwega (Generalized Anxiety Disorder)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/009095
Enrollment
100
Registered
2017-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed cases of Generalized Anxiety Disorder based on DSM IV criteria Health Condition 2: F411- Generalized anxiety disorder

Interventions

Intervention1: GROUP I: Group I: 1. Ashvagandha churna (Bhava prakasha nighantu). In tablet form. Dose 1.5 gm (3 tablets of 500 mg each) twice daily Dosage form Tablet Route of Administrati

Sponsors

Central council for Research in Ayurvedic sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 to 45 years of either sex 2. Diagnosed Cases of GAD Based on DSM IV diagnostic criteria for Generalized Anxiety Disorder 3. Willing to give written informed consent for the participation.

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years and more than 45 years. 2. Depression 3. Social phobias 4. Hypertension 5. Cardiac diseases 6. Epilepsy 7. Asthma and COPD 8. Hyperthyroidism 9. Diabetes 10. Alcoholics and Drug addicts

Design outcomes

Primary

MeasureTime frame
Primary Outcome Measure To assess improvement in total Hamilton anxiety rating scale Timepoint: Periodically once in 4 weeks till 12 weeks duration

Secondary

MeasureTime frame
Secondary Outcome Measure To observe change in individual components of Hamilton anxiety rating scale Timepoint: At the end of study period of 3 years

Countries

India

Contacts

Public ContactDr D Sudhakar

Advanced centre for Ayurveda in Mental health & Neurosciences

acamhns.bengaluru@gmail.com08026567546

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026